Lactoferrin and the newborn: Current perspectives

Expert Review of Anti-Infective Therapy

Volumn 11, Issue 7, 2013, Pages 695-707

  Lingappan, Krithika ^a   Arunachalam, Athis ^a   Pammi, Mohan ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

immunomodulation; inflammation; lactoferrin; necrotizing enterocolitis; neonate; sepsis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LACTOFERRIN; OSTEOGENIC PROTEIN 1; PROBIOTIC AGENT; RECOMBINANT PROTEIN; TALACTOFERRIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ABSENCE OF SIDE EFFECTS; ADENOMATOUS POLYP; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; BREAST FEEDING; COLITIS; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ENTERITIS; EVIDENCE BASED MEDICINE; GASTRITIS; HELICOBACTER INFECTION; HUMAN; IMMUNOMODULATION; IMMUNOPROPHYLAXIS; INTESTINE INFECTION; IRON DEFICIENCY ANEMIA; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; METASTASIS; NEWBORN; NEWBORN SEPSIS; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN FUNCTION; REVIEW; TH1 TH2 BALANCE;

EID: 84880854801     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2013.811927     Document Type: Review

References (163)

1. Adams-Chapman I, Stoll BJ. Prevention of nosocomial infections in the neonatal intensive care unit. Curr. Opin. Pediatr. 14(2), 157-164 (2002
2. Stoll BJ, Hansen NI, Higgins RD et al.; National Institute of Child Health and Human Development. Very low birth weight preterm infants with early onset neonatal sepsis: The predominance of Gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr. Infect. Dis. J. 24(7), 635-639 (2005
3. Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. Int. J. Epidemiol. 35(3), 706-718 (2006
4. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 368(9543), 1271-1283 (2006
5. Fanaroff AA, Stoll BJ, Wright LL et al.; NICHD Neonatal Research Network. Trends in neonatal morbidity and mortality for very low birthweight infants. Am. J. Obstet. Gynecol. 196(2), 147.e1-147.e8 (2007
6. Lemons JA, Bauer CR, Oh W et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 107(1), E1 (2001
7. Stoll BJ, Hansen NI, Adams-Chapman I et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birthweight infants with neonatal infection. JAMA 292(19), 2357-2365 (2004
8. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century -A clinical super-challenge. N. Engl. J. Med. 360(5), 439-443 (2009
9. Blackwell TS, Christman JW. The role of nuclear factor-κ B in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17(1), 3-9 (1997
10. Neish AS. Molecular aspects of intestinal epithelial cell-bacterial interactions that determine the development of intestinal inflammation. Inflamm. Bowel Dis. 10(2), 159-168 (2004
11. Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro-And counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 103(4 Pt 1), 766-771 (1999
12. Ng PC, Li K, Wong RP et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch. Dis. Child. Fetal Neonatal Ed. 88(3), F209-F213 (2003
13. Harris MC, D'Angio CT, Gallagher PR, Kaufman D, Evans J, Kilpatrick L. Cytokine elaboration in critically ill infants with bacterial sepsis, necrotizing entercolitis, or sepsis syndrome: Correlation with clinical parameters of inflammation and mortality. J. Pediatr. 147(4), 462-468 (2005
14. Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. Eur. J. Pediatr. 158(SUPPL.. 1), S18-S22 (1999
15. Adams-Chapman I, Stoll BJ. Neonatal infection and long-Term neurodevelopmental outcome in the preterm infant. Curr. Opin. Infect. Dis. 19(3), 290-297 (2006
16. Moguilevsky N, Retegui LA, Masson PL. Comparison of human lactoferrins from milk and neutrophilic leucocytes. Relative molecular mass, isoelectric point, iron-binding properties and uptake by the liver. Biochem. J. 229(2), 353-359 (1985
17. Sá;nchez L, Calvo M, Brock JH. Biological role of lactoferrin. Arch. Dis. Child. 67(5), 657-661 (1992
18. Baker EN, Baker HM. A structural framework for understanding the multifunctional character of lactoferrin. Biochimie 91(1), 3-10 (2009
19. Ward PP, Paz E, Conneely OM. Multifunctional roles of lactoferrin: A critical overview. Cell. Mol. Life Sci. 62(22), 2540-2548 (2005
20. Hennart PF, Brasseur DJ, Delogne-Desnoeck JB, Dramaix MM, Robyn CE. Lysozyme, lactoferrin, and secretory immunoglobulin A content in breast milk: Influence of duration of lactation, nutrition status, prolactin status, and parity of mother. Am. J. Clin. Nutr. 53(1), 32-39 (1991
21. Masson PL, Heremans JF. Lactoferrin in milk from different species. Comp. Biochem. Physiol., B 39(1), 119-129 (1971
22. Masson P, Heremans J, Dive C. An iron-binding protein common to many external secretions. Clin. Chim. Acta, 14, 735-739 (1966
23. Masson PL, Heremans JF, Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130(3), 643-658 (1969
24. Bennett RM, Kokocinski T. Lactoferrin content of peripheral blood cells. Br. J. Haematol. 39(4), 509-521 (1978
25. Buccigrossi V, de Marco G, Bruzzese E et al. Lactoferrin induces concentrationdependent functional modulation of intestinal proliferation and differentiation. Pediatr. Res. 61(4), 410-414 (2007
26. Suzuki YA, Lopez V, Lönnerdal B. Mammalian lactoferrin receptors: Structure and function. Cell. Mol. Life Sci. 62(22), 2560-2575 (2005
27. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: A lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 62(22), 2588-2598 (2005
28. Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-Terminal region of bovine lactoferrin. J. Appl. Bacteriol. 73(6), 472-479 (1992
29. Yamauchi K, Tomita M, Giehl TJ, Ellison RT 3rd. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 61(2), 719-728 (1993
30. Farnaud S, Evans RW. Lactoferrin -A multifunctional protein with antimicrobial properties. Mol. Immunol. 40(7), 395-405 (2003
31. Orsi N. The antimicrobial activity of lactoferrin: Current status and perspectives. Biometals 17(3), 189-196 (2004
32. Leitch EC, Willcox MD. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J. Med. Microbiol. 48(9), 867-871 (1999
33. Qiu J, Hendrixson DR, Baker EN, Murphy TF, St Geme JW 3rd, Plaut AG. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proc. Natl Acad. Sci. USA 95(21), 12641-12646 (1998
34. Gomez HF, Ochoa TJ, Carlin LG, Cleary TG. Human lactoferrin impairs virulence of Shigella flexneri. J. Infect. Dis. 187(1), 87-95 (2003
35. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature 417(6888), 552-555 (2002
36. Venkatesh M, Rong L, Raad I, Versalovic J. Novel synergistic antibiofilm combinations for salvage of infected catheters. J. Med. Microbiol. 58(Pt 7), 936-944 (2009
37. Venkatesh MP, Rong L. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis. J. Med. Microbiol. 57(Pt 9), 1113-1121 (2008
38. Nibbering PH, Ravensbergen E, Welling MM et al. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibioticresistant bacteria. Infect. Immun. 69(3), 1469-1476 (2001
39. Tian H, Maddox IS, Ferguson LR, Shu Q. Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals 23(3), 593-596 (2010
40. Petschow BW, Talbott RD, Batema RP. Ability of lactoferrin to promote the growth of Bifidobacterium spp. in vitro is independent of receptor binding capacity and iron saturation level. J. Med. Microbiol. 48(6), 541-549 (1999
41. van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK. Antiviral activities of lactoferrin. Antiviral Res. 52(3), 225-239 (2001
42. Kondori N, Baltzer L, Dolphin GT, Mattsby-Baltzer I. Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial aβ region. Int. J. Antimicrob. Agents 37(1), 51-57 (2011
43. Elass E, Masson M, Mazurier J, Legrand D. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycanbinding ability of interleukin-8 in human endothelial cells. Infect. Immun. 70(4), 1860-1866 (2002
44. Yeom M, Park J, Lee B et al. Lactoferrin inhibits the inflammatory and angiogenic activation of bovine aortic endothelial cells. Inflamm. Res. 60(5), 475-482 (2011
45. Håversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell. Immunol. 220(2), 83-95 (2002
46. Curran CS, Demick KP, Mansfield JM. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell. Immunol. 242(1), 23-30 (2006
47. Zhang C, Li Y, Tang W, Kamiya N, Kim H. Lactoferrin activates BMP7 gene expression through the mitogen-Activated protein kinase ERK pathway in articular cartilage. Biochem. Biophys. Res. Commun. 431(1), 31-35 (2013
48. Kruzel ML, Bacsi A, Choudhury B, Sur S, Boldogh I. Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology 119(2), 159-166 (2006
49. Guillé;n C, McInnes IB, Vaughan DM et al. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-Transgenic mice. J. Immunol. 168(8), 3950-3957 (2002
50. Zagulski T, Lipinski P, Zagulska A, Broniek S, Jarzabek Z. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70(6), 697-704 (1989
51. Edde L, Hipolito RB, Hwang FF, Headon DR, Shalwitz RA, Sherman MP. Lactoferrin protects neonatal rats from gut-related systemic infection. Am. J. Physiol. Gastrointest. Liver Physiol. 281(5), G1140-G1150 (2001
52. Venkatesh MP, Pham D, Kong L, Weisman LE. Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection. Adv. Ther. 24(5), 941-954 (2007
53. Artym J, Zimecki M, Kruzel ML. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin. Int. Immunopharmacol. 4(9), 1149-1157 (2004
54. Lee WJ, Farmer JL, Hilty M, Kim YB. The protective effects of lactoferrin feeding against endotoxin lethal shock in germ-free piglets. Infect. Immun. 66(4), 1421-1426 (1998
55. Dial EJ, Lichtenberger LM. Effect of lactoferrin on Helicobacter felis induced gastritis. Biochem. Cell Biol. 80(1), 113-117 (2002
56. Togawa J, Nagase H, Tanaka K et al. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J. Gastroenterol. Hepatol. 17(12), 1291-1298 (2002
57. Kruzel ML, Harari Y, Chen CY, Castro GA. Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation 24(1), 33-44 (2000
58. Gomez HF, Ochoa TJ, Herrera-Insua I, Carlin LG, Cleary TG. Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis. Infect. Immun. 70(12), 7050-7053 (2002
59. Yajima M, Yajima T, Kuwata T. Intraperitoneal injection of lactoferrin ameliorates severe albumin extravasation and neutrophilia in LPS-induced inflammation in neonatal rats. Biomed. Res. 26(6), 249-255 (2005
60. Hu W, Zhao J, Wang J, Yu T, Wang J, Li N. Transgenic milk containing recombinant human lactoferrin modulates the intestinal flora in piglets. Biochem. Cell Biol. 90(3), 485-496 (2012
61. Sherman MP, Bennett SH, Hwang FF, Yu C Neonatal small bowel epithelia: Enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG. Biometals 17(3), 285-289 (2004
62. Prgomet C, Prenner ML, Schwarz FJ, Pfaffl MW. Effect of lactoferrin on selected immune system parameters and the gastrointestinal morphology in growing calves. J. Anim. Physiol. Anim. Nutr. 91(3-4), 109-119 (2007
63. Fischer R, Debbabi H, Dubarry M, Boyaka P, Tomé; D. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem. Cell Biol. 84(3), 303-311 (2006
64. Levy O. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7(5), 379-390 (2007
65. Hirotani Y, Ikeda K, Kato R et al. Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells. Yakugaku Zasshi 128(9), 1363-1368 (2008
66. Trümpler U, Straub PW, Rosenmund A. Antibacterial prophylaxis with lactoferrin in neutropenic patients. Eur. J. Clin. Microbiol. Infect. Dis. 8(4), 310-313 (1989
67. Tomita M, Wakabayashi H, Yamauchi K, Teraguchi S, Hayasawa H. Bovine lactoferrin and lactoferricin derived from milk: Production and applications. Biochem. Cell Biol. 80(1), 109-112 (2002
68. Tomita M, Wakabayashi H, Shin K, Yamauchi K, Yaeshima T, Iwatsuki K. Twenty-five years of research on bovine lactoferrin applications. Biochimie 91(1), 52-57 (2009
69. Garcí;a-Montoya IA, Cendó;n TS, Aré;valo-Gallegos S, Rascó;n-Cruz Q. Lactoferrin a multiple bioactive protein: An overview. Biochim. Biophys. Acta 1820(3), 226-236 (2012
70. Akinbi H, Meinzen-Derr J, Auer C et al. Alterations in the host defense properties of human milk following prolonged storage or pasteurization. J. Pediatr. Gastroenterol. Nutr. 51(3), 347-352 (2010
71. Group ETI. Lactoferrin immunoprophylaxis for very preterm infants. Arch. Dis. Child Fetal Neonatal. Ed. 98(1), F2-F4 (2013
72. Kawakami H, Lönnerdal B. Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes. Am. J. Physiol. 261(5 Pt 1), G841-G846 (1991
73. Vogel HJ. Lactoferrin, a bird's eye view. Biochem. Cell Biol. 90(3), 233-244 (2012
74. Almond RJ, Flanagan BF, Antonopoulos A et al. Differential immunogenicity and allergenicity of native and recombinant human lactoferrins: Role of glycosylation. Eur. J. Immunol. 43(1), 170-181 (2013
75. Pammi M, Abrams SA. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst. Rev. 10, CD007138 (2011
76. Ochoa TJ, Pezo A, Cruz K, Chea-Woo E, Cleary TG. Clinical studies of lactoferrin in children. Biochem. Cell Biol. 90(3), 457-467 (2012
77. Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Modeo ME, Aiello F. Effect of lactoferrin SUPPL.ementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med. Sci. Monit. 13(4), CR187-CR190 (2007
78. Kaito M, Iwasa M, Fujita N et al. Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin. J. Gastroenterol. Hepatol. 22(11), 1894-1897 (2007
79. Viani RM, Gutteberg TJ, Lathey JL, Spector SA. Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine. AIDS 13(10), 1273-1274 (1999
80. Naidu AS, Chen J, Martinez C, Tulpinski J, Pal BK, Fowler RS. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer. J. Reprod. Med. 49(11), 859-866 (2004
81. Kozu T, Iinuma G et al. Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled trial. Cancer Prev. Res. 2(11), 975-983 (2009
82. Parikh PM, Vaid A, Advani SH et al. Randomized, double-blind, placebo-controlled Phase II study of single-Agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy. J. Clin. Oncol. 29(31), 4129-4136 (2011
83. Manzoni P, Rinaldi M, Cattani S et al.; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology. Bovine lactoferrin SUPPL.ementation for prevention of late-onset sepsis in very low-birth-weight neonates: A randomized trial. JAMA 302(13), 1421-1428 (2009
84. Manzoni P, Rinaldi M, Meyer P, Casa D, Pugni L, Mosca F. Bovine lactoferrin SUPPL.ementation for prevention of necrotizing enterocolitis in preterm very low birth weight neonates: A randomized trial. In: Pediatric Academic Societies Meeting. Denver, CO, USA (2011
85. Manzoni P, Stolfi I, Messner H et al.; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections-The Italian Society of Neonatology. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: A randomized controlled trial. Pediatrics 129(1), 116-123 (2012
86. Pammi M, Eddama O, Weisman LE. Patient isolation measures for infants with Candida colonization or infection for preventing or reducing transmission of Candida in neonatal units. Cochrane Database Syst. Rev. 11, CD006068 (2011
87. Ronayne de Ferrer PA, Baroni A, Sambucetti ME, Lopez NE, Ceriani Cernadas JM. Lactoferrin levels in term and preterm milk. J. Am. Coll. Nutr. 19(3), 370-373 (2000
88. Sherman MP. New concepts of microbial translocation in the neonatal intestine: Mechanisms and prevention. Clin. Perinatol. 37(3), 565-579 (2010
89. Raghuveer TS, McGuire EM, Martin SM et al. Lactoferrin in the preterm infants' diet attenuates iron-induced oxidation products. Pediatr. Res. 52(6), 964-972 (2002
90. King JC Jr, Cummings GE, Guo N et al. A double-blind, placebo-controlled, pilot study of bovine lactoferrin SUPPL.ementation in bottle-fed infants. J. Pediatr. Gastroenterol. Nutr. 44(2), 245-251 (2007
91. Sherman MP. Lactoferrin and necrotizing enterocolitis. Clin. Perinatol. 40(1), 79-91 (2013
92. Legrand D. Lactoferrin, a key molecule in immune and inflammatory processes. Biochem. Cell Biol. 90(3), 252-268 (2012
93. Leitch EC, Willcox MD. Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin. Curr. Eye Res. 19(1), 12-19 (1999
94. Venkatesh MP, Rong L. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis. J. Med. Microbiol. 57(Pt 9), 1113-1121 (2008
95. Williams TJ, Schneider RP, Willcox MD. The effect of protein-coated contact lenses on the adhesion and viability of Gram negative bacteria. Curr. Eye Res. 27(4), 227-235 (2003
96. Berlutti F, Ajello M, Bosso P et al. Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans. Biometals 17(3), 271-278 (2004
97. Aguilera O, André;s MT, Heath J, Fierro JF, Douglas CW. Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens. FEMS Immunol. Med. Microbiol. 21(1), 29-36 (1998
98. Visca P, Berlutti F, Vittorioso P, Dalmastri C, Thaller MC, Valenti P. Growth and adsorption of Streptococcus mutans 6715-13 to hydroxyapatite in the presence of lactoferrin. Med. Microbiol. Immunol. 178(2), 69-79 (1989
99. Schaible UE, Collins HL, Priem F, Kaufmann SH. Correction of the iron overload defect in β-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J. Exp. Med. 196(11), 1507-1513 (2002
100. Kuipers ME, de Vries HG, Eikelboom MC, Meijer DK, Swart PJ. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob. Agents Chemother. 43(11), 2635-2641 (1999
101. Viejo-Dí;az M, André;s MT, Fierro JF. Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity. Antimicrob. Agents Chemother. 48(4), 1242-1248 (2004
102. Lupetti A, Danesi R, van 't Wout JW, van Dissel JT, Senesi S, Nibbering PH. Antimicrobial peptides: Therapeutic potential for the treatment of Candida infections. Expert Opin. Investig. Drugs 11(2), 309-318 (2002
103. Lupetti A, Paulusma-Annema A, Welling MM et al. Synergistic activity of the N-Terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrob. Agents Chemother. 47(1), 262-267 (2003
104. Lupetti A, Paulusma-Annema A, Welling MM, Senesi S, van Dissel JT, Nibbering PH. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob. Agents Chemother. 44(12), 3257-3263 (2000
105. Wakabayashi H, Abe S, Okutomi T, Tansho S, Kawase K, Yamaguchi H. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol. Immunol. 40(11), 821-825 (1996
106. Wakabayashi H, Okutomi T, Abe S, Hayasawa H, Tomita M, Yamaguchi H. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds. Adv. Exp. Med. Biol. 443, 229-237 (1998
107. Wakabayashi H, Takase M, Tomita M. Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 9(16), 1277-1287 (2003
108. Hasegawa K, Motsuchi W, Tanaka S, Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn. J. Med. Sci. Biol. 47(2), 73-85 (1994
109. Marchetti M, Longhi C, Conte MP, Pisani S, Valenti P, Seganti L. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res. 29(2-3), 221-231 (1996
110. Marchetti M, Pisani S, Antonini G, Valenti P, Seganti L, Orsi N Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2. Biometals 11(2), 89-94 (1998
111. Jenssen H, Sandvik K, Andersen JH, Hancock RE, Gutteberg TJ. Inhibition of HSV cell-To-cell spread by lactoferrin and lactoferricin. Antiviral Res. 79(3), 192-198 (2008
112. Ammendolia MG, Marchetti M, Superti F. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in green monkey kidney cells. Antiviral Res. 76(3), 252-262 (2007
113. Beljaars L, Bakker HI, van der Strate BW et al. The antiviral protein human lactoferrin is distributed in the body to cytomegalovirus (CMV) infection-prone cells and tissues. Pharm. Res. 19(1), 54-62 (2002
114. Beljaars L, van der Strate BW, Bakker HI et al. Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo. Antiviral Res. 63(3), 197-208 (2004
115. Harmsen MC, Swart PJ, de Bé;thune MP et al. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 172(2), 380-388 (1995
116. Puddu P, Borghi P, Gessani S, Valenti P, Belardelli F, Seganti L. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. Int. J. Biochem. Cell Biol. 30(9), 1055-1062 (1998
117. Berkhout B, Floris R, Recio I, Visser S The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1. Biometals 17(3), 291-294 (2004
118. Hara K, Ikeda M, Saito S et al. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatol. Res. 24(3), 228 (2002
119. Tanaka K, Ikeda M, Nozaki A et al. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: A pilot study. Jpn. J. Cancer Res. 90(4), 367-371 (1999
120. Iwasa M, Kaito M, Ikoma J et al. Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b. Am. J. Gastroenterol. 97(3), 766-767 (2002
121. Ikeda M, Nozaki A, Sugiyama K et al. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res. 66(1), 51-63 (2000
122. Yi M, Kaneko S, Yu DY, Murakami S. Hepatitis C virus envelope proteins bind lactoferrin. J. Virol. 71(8), 5997-6002 (1997
123. Sano H, Nagai K, Tsutsumi H, Kuroki Y. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur. J. Immunol. 33(10), 2894-2902 (2003
124. Superti F, Ammendolia MG, Valenti P, Seganti L. Antirotaviral activity of milk proteins: Lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med. Microbiol. Immunol. 186(2-3), 83-91 (1997
125. Marchetti M, Superti F, Ammendolia MG, Rossi P, Valenti P, Seganti L. Inhibition of poliovirus type 1 infection by iron-, manganese-And zinc-saturated lactoferrin. Med. Microbiol. Immunol. 187(4), 199-204 (1999
126. Arnold D, Di Biase AM, Marchetti M et al. Antiadenovirus activity of milk proteins: Lactoferrin prevents viral infection. Antiviral Res. 53(2), 153-158 (2002
127. Lin TY, Chu C, Chiu CH. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J. Infect. Dis. 186(8), 1161-1164 (2002
128. Di Biase AM, Pietrantoni A, Tinari A et al. Heparin-interacting sites of bovine lactoferrin are involved in anti-Adenovirus activity. J. Med. Virol. 69(4), 495-502 (2003
129. Omata Y, Satake M, Maeda R et al. Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. J. Vet. Med. Sci. 63(2), 187-190 (2001
130. Tanaka T, Omata Y, Narisawa M et al. Growth inhibitory effect of bovine lactoferrin on Toxoplasma gondii tachyzoites in murine macrophages: Role of radical oxygen and inorganic nitrogen oxide in Toxoplasma growth-inhibitory activity. Vet. Parasitol. 68(1-2), 27-33 (1997
131. Cirioni O, Giacometti A, Barchiesi F, Scalise G. Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. J. Antimicrob. Chemother. 46(4), 577-582 (2000
132. Konishi M, Iwasa M, Yamauchi K et al. Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C. Hepatol. Res. 36(1), 27-32 (2006
133. Appelmelk BJ, An YQ, Geerts M et al. Lactoferrin is a lipid A-binding protein. Infect. Immun. 62(6), 2628-2632 (1994
134. Elass-Rochard E, Legrand D, Salmon V et al. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide- binding protein. Infect. Immun. 66(2), 486-491 (1998
135. Brandenburg K, Jürgens G, Müller M, Fukuoka S, Koch MH. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem. 382(8), 1215-1225 (2001
136. Baveye S, Elass E, Mazurier J, Legrand D. Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils. FEBS Lett. 469(1), 5-8 (2000
137. Baveye S, Elass E, Fernig DG, Blanquart C, Mazurier J, Legrand D. Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14- lipopolysaccharide complex. Infect. Immun. 68(12), 6519-6525 (2000
138. Britigan BE, Lewis TS, Waldschmidt M, McCormick ML, Krieg AM. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J. Immunol. 167(5), 2921-2928 (2001
139. Sawatzki G, Rich IN. Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 15(2), 371-385 (1989
140. Broxmeyer HE, Williams DE, Cooper S et al. Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. J. Clin. Invest. 79(3), 721-730 (1987
141. Machnicki M, Zimecki M, Zagulski T. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol. 74(5), 433-439 (1993
142. Kruzel ML, Harari Y, Mailman D, Actor JK, Zimecki M. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin. Exp. Immunol. 130(1), 25-31 (2002
143. Togawa J, Nagase H, Tanaka K et al. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am. J. Physiol. Gastrointest. Liver Physiol. 283(1), G187-G195 (2002
144. Kai K, Komine K, Komine Y et al. Lactoferrin stimulates A Staphylococcus aureus killing activity of bovine phagocytes in the mammary gland. Microbiol. Immunol. 46(3), 187-194 (2002
145. Kijlstra A, Jeurissen SH. Modulation of classical C3 convertase of complement by tear lactoferrin. Immunology 47(2), 263-270 (1982
146. Rainard P. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae. Immunology 79(4), 648-652 (1993
147. Zimecki M, Artym J, Chodaczek G et al. Immunoregulatory function of lactoferrin in immunosuppressed and autoimmune animals. Postepy. Hig. Med. Dosw. (Online) 61, 283-287 (2007
148. Zimecki M, Kocieba M, Chodaczek G, Houszka M, Kruzel ML. Lactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats. J. Neuroimmunol. 182(1-2), 160-166 (2007
149. Zimecki M, Mazurier J, Machnicki M, Wieczorek Z, Montreuil J, Spik G. Immunostimulatory activity of lactotransferrin and maturation of CD4-CD8-murine thymocytes. Immunol. Lett. 30(1), 119-123 (1991
150. Zimecki M, Mazurier J, Spik G, Kapp JA. Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology 86(1), 122-127 (1995
151. Yamauchi K, Wakabayashi H, Hashimoto S, Teraguchi S, Hayasawa H, Tomita M. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv. Exp. Med. Biol. 443, 261-265 (1998
152. Shimizu K, Matsuzawa H, Okada K et al. Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity. Arch. Virol. 141(10), 1875-1889 (1996
153. Shau H, Kim A, Golub SH. Modulation of natural killer and lymphokine-Activated killer cell cytotoxicity by lactoferrin. J. Leukoc. Biol. 51(4), 343-349 (1992
154. Kuhara T, Yamauchi K, Tamura Y, Okamura H. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine. J. Interferon Cytokine Res. 26(7), 489-499 (2006
155. Damiens E, Mazurier J, el Yazidi I et al. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim. Biophys. Acta 1402(3), 277-287 (1998
156. Miyauchi H, Hashimoto S, Nakajima M, Shinoda I, Fukuwatari Y, Hayasawa H. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: Identification of its active domain. Cell. Immunol. 187(1), 34-37 (1998
157. de la Rosa G, Yang D, Tewary P, Varadhachary A, Oppenheim JJ. Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J. Immunol. 180(10), 6868-6876 (2008
158. Spadaro M, Caorsi C, Ceruti P et al. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. FASEB J. 22(8), 2747-2757 (2008
159. Wakabayashi H, Takakura N, Yamauchi K et al. Effect of lactoferrin feeding on the host antifungal response in guinea-pigs infected or immunised with Trichophyton mentagrophytes. J. Med. Microbiol. 51(10), 844-850 (2002
160. Takakura N, Wakabayashi H, Ishibashi H et al. Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J. Med. Microbiol. 53(Pt 6), 495-500 (2004
161. Ishii K, Takamura N, Shinohara M et al. Long-Term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol. Res. 25(3), 226-233 (2003
162. Zimecki M, Kocieba M, Kruzel M. Immunoregulatory activities of lactoferrin in the delayed type hypersensitivity in mice are mediated by a receptor with affinity to mannose. Immunobiology 205(1), 120-131 (2002
163. Chodaczek G, Zimecki M, Lukasiewicz J, Lugowski C. A complex of lactoferrin with monophosphoryl lipid A is an efficient adjuvant of the humoral and cellular immune response in mice. Med. Microbiol. Immunol. 195(4), 207-216 (2006